European committee takes a second look at Alzheimer's drug and now says it should be approved
A European regulatory committee now recommends approval of the Alzheimer's treatment lecanemab a few months after rejecting ...
Verywell Health on MSN1h
Zepbound Cuts the Risk of Progressing to Diabetes by 94%, Eli Lilly Data Shows
Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...
tnp.straitstimes12m
Smart toilet, AI platform at Eli Lilly’s $42m hub in S’pore
How can clinical trial participants be prevented from recording information inaccurately? One solution for pharmaceutical giant Eli Lilly and Company comes in the form of a smart toilet that detects ...